You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Makary
since
auto-detected in 3 stories
11 days ago
Makary pointed to three bottlenecks: hospital contracting, ethical reviews and approvals and the Investigational New Drug applications process
FDA chief Marty Makary says 'everything should be over-the-counter' unless drug is unsafe or addictive ⊕
Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year.
7 months ago
FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says ○
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually determined after an approval in the U.S.
page 1 of 1